$2.38 EPS Expected for UnitedHealth Group Inc (UNH) This Quarter

$2.38 EPS Expected for UnitedHealth Group Inc (UNH) This Quarter

Equities analysts expect UnitedHealth Group Inc (NYSE:UNH) to report $2.38 earnings per share for the current quarter, according to Zacks Investment Research. Seven analysts have made estimates for UnitedHealth Group’s earnings, with the highest EPS estimate coming in at $2.41 and the lowest estimate coming in at $2.35. UnitedHealth Group posted earnings per share of $1.96 during the same quarter last year, which would indicate a positive year-over-year growth rate of 21.4%. The business is expected to announce its next earnings results on Tuesday, July 18th.

According to Zacks, analysts expect that UnitedHealth Group will report full year earnings of $9.80 per share for the current fiscal year, with EPS estimates ranging from $9.75 to $9.85. For the next financial year, analysts forecast that the business will post earnings of $10.75 per share, with EPS estimates ranging from $10.67 to $11.00. Zacks’ EPS calculations are an average based on a survey of sell-side research analysts that cover UnitedHealth Group.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, April 18th. The healthcare conglomerate reported $2.37 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.17 by $0.20. The company had revenue of $48.72 billion for the quarter, compared to the consensus estimate of $48.21 billion. UnitedHealth Group had a return on equity of 21.20% and a net margin of 3.92%. UnitedHealth Group’s quarterly revenue was up 9.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.81 EPS.

Several equities research analysts recently issued reports on UNH shares. Barclays PLC reiterated a “buy” rating and issued a $187.00 price objective on shares of UnitedHealth Group in a report on Monday, January 9th. Jefferies Group LLC reiterated a “buy” rating and issued a $186.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 10th. Argus reiterated a “buy” rating and issued a $170.00 price objective on shares of UnitedHealth Group in a report on Monday, January 23rd. Leerink Swann reiterated an “outperform” rating and issued a $185.00 price objective on shares of UnitedHealth Group in a report on Tuesday, January 24th. Finally, Cantor Fitzgerald started coverage on UnitedHealth Group in a report on Monday, February 6th. They issued an “overweight” rating and a $200.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating and twenty-three have given a buy rating to the stock. UnitedHealth Group has an average rating of “Buy” and an average price target of $182.65.

Shares of UnitedHealth Group (NYSE:UNH) traded up 0.06% during trading on Monday, reaching $174.12. The company’s stock had a trading volume of 2,188,959 shares. The stock has a 50 day moving average of $168.62 and a 200-day moving average of $160.46. UnitedHealth Group has a 1-year low of $128.53 and a 1-year high of $176.14. The company has a market capitalization of $169.77 billion, a PE ratio of 22.29 and a beta of 0.68.

In other news, Director Gail R. Wilensky sold 5,310 shares of the company’s stock in a transaction dated Thursday, February 23rd. The stock was sold at an average price of $162.31, for a total transaction of $861,866.10. Following the completion of the transaction, the director now directly owns 60,175 shares of the company’s stock, valued at approximately $9,767,004.25. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP D Ellen Wilson sold 14,000 shares of the company’s stock in a transaction dated Wednesday, April 19th. The stock was sold at an average price of $170.54, for a total value of $2,387,560.00. Following the transaction, the executive vice president now directly owns 31,993 shares of the company’s stock, valued at $5,456,086.22. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 45,148 shares of company stock valued at $7,620,249. Insiders own 1.65% of the company’s stock.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in UNH. Jackson Grant Investment Advisers Inc. boosted its position in UnitedHealth Group by 0.4% in the fourth quarter. Jackson Grant Investment Advisers Inc. now owns 1,093 shares of the healthcare conglomerate’s stock valued at $175,000 after buying an additional 4 shares in the last quarter. Adirondack Trust Co. boosted its position in UnitedHealth Group by 0.5% in the first quarter. Adirondack Trust Co. now owns 990 shares of the healthcare conglomerate’s stock valued at $162,000 after buying an additional 5 shares in the last quarter. Beck Mack & Oliver LLC boosted its position in UnitedHealth Group by 0.3% in the third quarter. Beck Mack & Oliver LLC now owns 2,708 shares of the healthcare conglomerate’s stock valued at $379,000 after buying an additional 8 shares in the last quarter. Paradigm Financial Advisors LLC boosted its position in UnitedHealth Group by 0.4% in the first quarter. Paradigm Financial Advisors LLC now owns 2,761 shares of the healthcare conglomerate’s stock valued at $452,000 after buying an additional 11 shares in the last quarter. Finally, Parkside Financial Bank & Trust boosted its position in UnitedHealth Group by 1.4% in the first quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock valued at $140,000 after buying an additional 12 shares in the last quarter. 86.67% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Get a free copy of the Zacks research report on UnitedHealth Group (UNH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Related posts

Leave a Comment